Skip to search formSkip to main contentSkip to account menu

Finasteride:MCnc:Pt:Ser/Plas:Qn

Known as: Finasteride::Pt:Soro/Plas:Qn, Finasteriid:MCnc:Pt:S/P:Qn, Finasteride:Massa concentratie:Moment:Serum of plasma:Kwantitatief 
National Institutes of Health

Related topics

Related topics

4 relations
FinasteridePlasSerumUnit of Mass Concentration

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Imaging prostate cancer (PCa) with [99m Tc(CO)3 ]finasteride dithiocarbamate.
This investigation aimed to modify finasteride (1) to finasteride dithiocarbamate (2) for subsequent synthesis of the rhenium… 
2013
2013
Änderung bei Finasterid-Filmtabletten
des mRCC — Seit Einführung der Tyrosinkinase-Inhibitoren (TKI) beim metastasierten Nierenzellkarzinom (mRCC) hat sich die… 
2013
2013
Study preparation of Finasteride Dispersible Tablets and its vitro dissolution
  • Ma Ru
  • 2013
  • Corpus ID: 102326840
Objective To prepare Finasteride Dispersible Tablets and study the characteristics in vitro dissolution.Methods With the… 
2011
2011
RP HPLC method for the determination of finasteride andtamsulosin in bulk and pharmaceutical formulations
A simple, sensitive, precise and specific reverse phase high performance liquid chromatographic method was developed and… 
2007
2007
Comparison of therapeutic effects of Finasteride jel and tablet in treatment of Androgenic Alopecia
2005
2005
[Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].
OBJECTIVE To investigate whether 5alpha-reductase inhibitor and dihydrotestosterone (DHT) play a role in spermatogenesis in male… 
2003
2003
Formulations de finastéride
Cette invention porte sur des formulations pharmaceutiques de finasteride qui comprennent Gelucire®. 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)